BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35576836)

  • 21. NREP, transcriptionally upregulated by HIF-1α, aggravates breast cancer cell growth and metastasis by promoting glycolysis.
    Ruan Y; Qiao J; Wang J; Liu Z
    Cell Death Discov; 2024 May; 10(1):210. PubMed ID: 38697993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1.
    Chang L; Xi L; Liu Y; Liu R; Wu Z; Jian Z
    Mol Med Rep; 2018 Jan; 17(1):342-349. PubMed ID: 29115436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.
    Ponnusamy L; Natarajan SR; Manoharan R
    J Cell Biochem; 2022 Apr; 123(4):759-771. PubMed ID: 35048405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
    Hu Y; Mu H; Deng Z
    Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
    Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth.
    Yi X; Qi M; Huang M; Zhou S; Xiong J
    Front Pharmacol; 2022; 13():796763. PubMed ID: 35350760
    [No Abstract]   [Full Text] [Related]  

  • 27. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
    J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGF-BB/PDGFRβ promotes epithelial-mesenchymal transition by affecting PI3K/AKT/mTOR-driven aerobic glycolysis in Wilms' tumor G401 cells.
    Guo JQ; Wang CD; Tang HY; Sang BT; Liu X; Yi FP; Wu XM
    Cell Biol Int; 2022 Jun; 46(6):907-921. PubMed ID: 35165984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
    Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXC13 promotes cell proliferation, metastasis and glycolysis in breast cancer by regulating DNMT3A.
    Li H; Gao P; Chen H; Zhao J; Zhang X; Li G; Wang L; Qin L
    Exp Ther Med; 2023 Sep; 26(3):439. PubMed ID: 37614427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer.
    Tang Z; Li L; Tang Y; Xie D; Wu K; Wei W; Xiao Q
    Cancer Sci; 2018 Aug; 109(8):2590-2598. PubMed ID: 29896817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of hypoxia-inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors.
    Shen N; Wang Y; Sun X; Bai X; He J; Cui Q; Qian J; Zhu H; Chen Y; Xing R; Liu Q; Wu Y; Li J; Lai W; Sun S; Ji N; Liu Y
    Brain Behav; 2020 Aug; 10(8):e01718. PubMed ID: 32533646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT5 functions as a tumor suppressor in renal cell carcinoma by reversing the Warburg effect.
    Yihan L; Xiaojing W; Ao L; Chuanjie Z; Haofei W; Yan S; Hongchao H
    J Transl Med; 2021 Dec; 19(1):521. PubMed ID: 34930316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
    BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
    Shi L; He C; Li Z; Wang Z; Zhang Q
    Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway.
    Xu J; Li X; Zhang P; Luo J; Mou E; Liu S
    Oncol Lett; 2022 May; 23(5):147. PubMed ID: 35350590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
    Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
    Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.